CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS


如何引用文章

全文:

详细

The article is dedicated to the modern methods of insulin administration; main advantages of continuous subcutaneous insulin pump infusion over regimen of multiple injections of insulin are discussed. The results of clinical studies demonstrating the effectiveness and advantages of insulin pump therapy, namely the elimination of dawn phenomenon, decrease in diurnal variability of glycemia, reduction of level of glycated hemoglobin, decrease in insulin requirements, lower incidence of hypoglycemia and ketoacidosis, are presented. Main correctable and non-correctable factors supporting chronic decompensation of diabetes are described. It is emphasized that lack of participation of the patient, as well as lack of his awareness about the disease and the performance of device leads to poor compensation of diabetes.

参考

  1. Анциферов М.Б., Котешкова О.М. Новые способы введения инсулина. Инсулиновая помпа. Обучающий фрагмент для школ обучения больных сахарным диабетом. Москва, 2006.
  2. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Москва, 2009.
  3. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. N Engl J Med 2010;363:311-20.
  4. Bode BW, Steed RD, Davidson P. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996;19(4):324-27.
  5. Bode BW, Strange P. Efficacy, safety and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 2001;24(1):69-72.
  6. Bruttomesso D, Crazzolara D, Maran A, et al. Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25(3):326-32.
  7. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125(2):177-88.
  8. Fox LA, Buckloh LM, Smith SD, et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes Diabetes Care 2005;28(6):1277-81.
  9. Chase HP, Horner B, McFann K, et al. The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 2006;29(5);1012-15.
  10. Hirsch IB, Bode BW, Garg S, et al. Continuous subcutaneous insulin infusion (CSII)of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005;28(3):533-38.
  11. King H, Aubert RE, еt al. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21(9):1414-31.
  12. Linkeschova R, Raoul M, Bottt U, Berger M. Better diabetes control, quality of life and less severe hypoglycaemias with insulin pump treatment. Diabetologia 2000;43(suppl. 1):748.
  13. Linkeschova R, Raoul M, Bottt U, et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy:an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002;19(9):746-51.
  14. Norgaard K. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark. Diabet Med 2003;20(4):307-11.
  15. Pickup J, Keen H. Continuous subcutaneous insulin infusion in type 1 diabetes: Is beneficial in selected patients and should be more widely available Continuous subcutaneous insulin infusion in type 1 diabetes. BMJ 2001;322(5):1262-63.
  16. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1978;1(1):204-07.
  17. Rodrigues AS, Reid HA, Ismail K, Amiel SA. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in type 1diabetes`mellitus: a clinical audit in a specialist service. Diabet Med 2005;22(6);842-49.
  18. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin - dependent diabetes mellitus. N Engl J Med 1993;329(9):977-86.
  19. The DCCT Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995;18(3);361-76.
  20. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. Diabetes Care 2003;26(4);1079-87.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2010
##common.cookie##